1. Home
  2. RJET vs SPRY Comparison

RJET vs SPRY Comparison

Compare RJET & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RJET

Republic Airways Holdings Inc.

N/A

Current Price

$20.78

Market Cap

930.0M

Sector

N/A

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$7.45

Market Cap

823.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RJET
SPRY
Founded
1982
2015
Country
United States
United States
Employees
8400
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.0M
823.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RJET
SPRY
Price
$20.78
$7.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
111.5K
1.7M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
N/A
$87.40
Revenue Next Year
N/A
$81.64
P/E Ratio
$0.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.37
$6.66
52 Week High
$23.88
$18.63

Technical Indicators

Market Signals
Indicator
RJET
SPRY
Relative Strength Index (RSI) 53.38 35.06
Support Level $16.65 $6.66
Resistance Level $21.31 $8.61
Average True Range (ATR) 1.87 0.52
MACD 0.21 -0.10
Stochastic Oscillator 63.95 14.57

Price Performance

Historical Comparison
RJET
SPRY

About RJET Republic Airways Holdings Inc.

Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: